{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:38:38Z","timestamp":1770385118618,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,5]]},"DOI":"10.7759\/cureus.103052","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:31:22Z","timestamp":1770334282000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Feasibility and Safety of Daily Inter-facility Travel for Proton Beam Therapy During Chemotherapy-Induced Myelosuppression in Children With Cancer"],"prefix":"10.7759","author":[{"given":"Yu","family":"Furui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Mizushiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Koiwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Morokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900500524751","article-title":"Proton beam radiation therapy","volume":"24","author":"MacDonald SM","year":"2006","unstructured":"MacDonald SM, DeLaney TF, Loeffler JS. Proton beam radiation therapy. Cancer Invest. 2006, 24:199-208. 10.1080\/07357900500524751","journal-title":"Cancer Invest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-014-0074-6","article-title":"Proton radiotherapy for pediatric tumors: review of first clinical results","volume":"40","author":"Rombi B","year":"2014","unstructured":"Rombi B, Vennarini S, Vinante L, Ravanelli D, Amichetti M. Proton radiotherapy for pediatric tumors: review of first clinical results. Ital J Pediatr. 2014, 40:74. 10.1186\/s13052-014-0074-6","journal-title":"Ital J Pediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190601","article-title":"Paediatric proton therapy","volume":"93","author":"Thomas H","year":"2020","unstructured":"Thomas H, Timmermann B. Paediatric proton therapy. Br J Radiol. 2020, 93:20190601. 10.1259\/bjr.20190601","journal-title":"Br J Radiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102209","article-title":"Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines","volume":"98","author":"Mizumoto M","year":"2021","unstructured":"Mizumoto M, Fuji H, Miyachi M, et al.. Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines. Cancer Treat Rev. 2021, 98:102209. 10.1016\/j.ctrv.2021.102209","journal-title":"Cancer Treat Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25768","article-title":"A retrospective evaluation of the benefit of referring pediatric cancer patients to an external proton therapy center","volume":"63","author":"Munck af Rosenschold P","year":"2016","unstructured":"Munck af Rosenschold P, Engelholm SA, Brodin PN, et al.. A retrospective evaluation of the benefit of referring pediatric cancer patients to an external proton therapy center. Pediatr Blood Cancer. 2016, 63:262-9. 10.1002\/pbc.25768","journal-title":"Pediatr Blood Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001620","article-title":"Urgent proton beam therapy with interinstitutional transfer for patients with intracranial rhabdomyosarcoma: report of 3 cases","volume":"42","author":"Inaba M","year":"2020","unstructured":"Inaba M, Nakao T, Hosaka S, et al.. Urgent proton beam therapy with interinstitutional transfer for patients with intracranial rhabdomyosarcoma: report of 3 cases. J Pediatr Hematol Oncol. 2020, 42:e12-7. 10.1097\/MPH.0000000000001620","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2018.08.006","article-title":"Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors","volume":"23","author":"Nakao T","year":"2018","unstructured":"Nakao T, Fukushima H, Fukushima T, et al.. Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors. Rep Pract Oncol Radiother. 2018, 23:442-50. 10.1016\/j.rpor.2018.08.006","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001570","article-title":"Patient transfer to receive proton beam therapy during intensive multimodal therapy is safe and feasible for patients with newly diagnosed high-risk neuroblastoma","volume":"42","author":"Hosaka S","year":"2020","unstructured":"Hosaka S, Fukushima H, Nakao T, et al.. Patient transfer to receive proton beam therapy during intensive multimodal therapy is safe and feasible for patients with newly diagnosed high-risk neuroblastoma. J Pediatr Hematol Oncol. 2020, 42:e18-24. 10.1097\/MPH.0000000000001570","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/children8121086","article-title":"Update on febrile neutropenia in pediatric oncological patients undergoing chemotherapy","volume":"8","author":"Cennamo F","year":"2021","unstructured":"Cennamo F, Masetti R, Largo P, Argentiero A, Pession A, Esposito S. Update on febrile neutropenia in pediatric oncological patients undergoing chemotherapy. Children (Basel). 2021, 8:10.3390\/children8121086","journal-title":"Children (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher T","year":"2023","unstructured":"Lehrnbecher T, Robinson PD, Ammann RA, et al.. Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update. J Clin Oncol. 2023, 41:1774-85. 10.1200\/JCO.22.02224","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28558","article-title":"Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors","volume":"67","author":"Baliga S","year":"2020","unstructured":"Baliga S, Bajaj BV, Kabarriti R, et al.. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors. Pediatr Blood Cancer. 2020, 67:e28558. 10.1002\/pbc.28558","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2014.01.016","article-title":"Non-invasive anesthesia for children undergoing proton radiation therapy","volume":"111","author":"Owusu-Agyemang P","year":"2014","unstructured":"Owusu-Agyemang P, Grosshans D, Arunkumar R, et al.. Non-invasive anesthesia for children undergoing proton radiation therapy. Radiother Oncol. 2014, 111:30-4. 10.1016\/j.radonc.2014.01.016","journal-title":"Radiother Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72223-z","article-title":"Age as a decisive factor in general anaesthesia use in paediatric proton beam therapy","volume":"10","author":"Shimazu Y","year":"2020","unstructured":"Shimazu Y, Otsuki R, Murakami M, et al.. Age as a decisive factor in general anaesthesia use in paediatric proton beam therapy. Sci Rep. 2020, 10:15096. 10.1038\/s41598-020-72223-z","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref15","unstructured":"Association for Nuclear Technology in Medicine (ANTM). introduction to particle therapy facilities in Japan [Article in Japanese]. (2025). Accessed: January 13, 2026: https:\/\/www.antm.or.jp\/information\/clinic\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455906-evaluating-the-feasibility-and-safety-of-daily-inter-facility-travel-for-proton-beam-therapy-during-chemotherapy-induced-myelosuppression-in-children-with-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:31:24Z","timestamp":1770334284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455906-evaluating-the-feasibility-and-safety-of-daily-inter-facility-travel-for-proton-beam-therapy-during-chemotherapy-induced-myelosuppression-in-children-with-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.103052","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}